Rubicon Research Ltd IPO – Dates, Price Band & Lot Size
The Rubicon Research Ltd IPO will be live from 09 Oct'25 to 13 Oct'25 with an issue size of ₹1377.50 crores. The IPO is priced in the band of ₹0.00–₹485.00 per share with a minimum lot size of 30.00 shares. Stay updated with IPO dates, allotment status, and listing details.
Min Investment ₹14550.00
Subscribed Times 103.90x
Issues size ₹1378 Crores
Price Range ₹0.00 - ₹485.00
Open on 09 Oct'25
Close on 13 Oct'25
Rubicon Research Ltd IPO Details
Lot Size 30.00
Issue size ₹1378 Crores
Issue Type Book Building
Rubicon Research Ltd Shares Offered
Qualified Inst. Buyers 54.41
Non Inst. Buyers 27.20
Retails Ind. Buyers 18.14
Rubicon Research Ltd Subscription Status
(as of 14 Jan 2026) Overall Status 103.90x
Qualified Inst. Buyers 130.26x
Non Inst. Buyers 97.61x
Retails Ind. Buyers 35.47x
Rubicon Research Ltd IPO Timeline
09 Oct'25 Issue Open
13 Oct'25 Issue Close
14 Oct'25 Finalization of Basis of Allotment
15 Oct'25 Initiation of refund
15 Oct'25 Transfer of shares to Demat Account
16 Oct'25 Listing Date
Rubicon Research Ltd Objects of the offer
Grow our Portfolio of specialty Products and drug-device combinations.
Continue to develop new products and build leadership positions in regulated markets for generic products.
Expand our US market presence and leverage our intellectual property and product portfolio in other key regulated markets.
Pursue synergistic business development and external innovation opportunities.
Rubicon Research Ltd Company's Financials
Assets(cr) Mar 2025 1001.97 Mar 2024 846.87 Mar 2023 609.32
Gross Profit(cr) Mar 2025 231.11 Mar 2024 141.83 Mar 2023 25.01
Liabilities(cr) Mar 2025 460.99 Mar 2024 461.87 Mar 2023 322.94
Net Income(cr) Mar 2025 134.36 Mar 2024 91.01 Mar 2023 -16.89
Revenue(cr) Mar 2025 1284.27 Mar 2024 853.89 Mar 2023 393.52
Rubicon Research Ltd Peer Comparison
Script Name Rubicon Research Ltd Revenue(cr) 1073.84 Net Profit(cr) 167.54 EPS 0.00 Current Ratio 3.73
Script Name Sun Pharmaceutical Industries Limited Revenue(cr) 52578.40 Net Profit(cr) 10929.00 EPS 45.60 Current Ratio 11.86
Script Name Aurobindo Pharma Limited Revenue(cr) 31723.70 Net Profit(cr) 3485.88 EPS 59.81 Current Ratio 7.00
Script Name Zydus Lifesciences Limited Revenue(cr) 23241.50 Net Profit(cr) 4525.50 EPS 44.97 Current Ratio 12.16
Script Name Strides Pharma Science Limited Revenue(cr) 4565.34 Net Profit(cr) 3593.46 EPS 390.50 Current Ratio 59.40
Script Name Dr. Reddy's Laboratories Limited Revenue(cr) 32643.90 Net Profit(cr) 5655.10 EPS 67.79 Current Ratio 11.44
Script Name Alembic Pharmaceuticals Limited Revenue(cr) 6672.08 Net Profit(cr) 583.42 EPS 29.68 Current Ratio 7.50
Script Name Lupin Limited Revenue(cr) 22707.90 Net Profit(cr) 3281.62 EPS 71.95 Current Ratio 11.23
Rubicon Research Ltd IPO
Rubicon Research Ltd Company Contact Info
Medone House B-75 Road No.33,
Wagle Estate,
Thane (West)-400604
Phone : 022 6141 4000
Rubicon Research Ltd Registrar & Transfer Agent
MUFG Intime India Pvt Ltd
C-101 247 Park,
L B S Marg-Mumbai-400083
Phone : 91-22-49186000
Fax : 91-22-49186060
Rubicon Research Ltd Book Running Managers
Offer Related Information
Initial public offering of up to 28,405,841 equity shares of face value of Re. 1 each (Equity Shares) of Rubicon Research Limited (Formerly Known as Rubicon Research Private Limited)(the Company or the Issuer) for cash at a price of Rs. 485 per equity share (Including a Share Premium of Rs.484 per equity share) (Offer Price) aggregating up to Rs. 1377.50 crores (the Offer) comprising a fresh issue of up to 10,313,058 equity shares of face value of Re. 1 each aggregating up to Rs. 500.00 crores by the company (the Fresh Issue) and an offer for sale of up to 18,092,783 equity shares of face value of Re. 1 each aggregating up to Rs. 877.50 crores by the promoter selling shareholder, general Atlantic Singapore RR Pvt Ltd (the Offer for Sale).This offer includes a reservation of up to 39,863 equity shares of face value of Re.1 each, aggregating up to Rs. 1.75 Crore (Constituting up to 0.02% of the Post-Offer Paid-up Equity Share Capital), for subscription by eligible employees (Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. the company in consultation with the BRLMS, may offer a discount of up to Rs.46 to the offer price (Equivalent of Rs.46 Per Equity Share) to eligible employees bidding in the employee reservation portion (Employee Discount). the offer and the net offer shall constitute at least 17.24% and 17.22%, respectively, of the post-offer paid-up equity share capital of the company. A discount of Rs. 46 per equity share is being offered to eligible employees bidding in the employee reservation portion.
Rubicon Research Ltd IPO FAQs
What is the issue size of Rubicon Research Ltd IPO?
The issue size of Rubicon Research Ltd IPO is ₹ 1378 crore.
What is 'pre-apply' for Rubicon Research Ltd IPO?
'Pre-apply' lets you place your IPO application before the official opening date.
If I pre-apply for Rubicon Research Ltd IPO, when will my order get placed?
Your order will be placed automatically once the IPO opens for subscription.
When will I know if my Rubicon Research Ltd IPO order is placed?
You'll get a confirmation via SMS/email once your IPO order is successfully placed.
What are the open and close dates of the Rubicon Research Ltd IPO?
The IPO opens on 09 Oct and closes on 13 Oct.
What is the lot size and minimum order quantity of the Rubicon Research Ltd IPO?
The minimum order is 1 lot, which consists of 30.00 shares.
What is the allotment date for the Rubicon Research Ltd IPO?
The allotment is expected on 14 Oct.
Who is the registrar of the Rubicon Research Ltd IPO?
MUFG Intime India Pvt Ltd is the registrar for this IPO.
Where is the Rubicon Research Ltd IPO getting listed?
It will be listed on BSE,NSE.